Zaniolo, O., Bamfi, F. and Iannazzo, S. (2007) “Budget impact of rosiglitazone in type 2 diabetes”, Farmeconomia. Health economics and therapeutic pathways, 8(1), pp. 15–26. doi: 10.7175/fe.v8i1.252.